The advantages of the biotechnology are many more and the aid of the computer technology in the bio science field has also increase the importance of the biotechnology. The simple type of the life that is spending in this age is only due to the aid of the biotechnology to this arena. The improvement in the field of the biotechnology and in the field of the bio science has the great importance in the markets of the today. The bio technology is helpful for all of us and for all the people because it is providing the method of the treatment that is risk free, and free of the side effect that was the worst aspect of the previous technology.

There is the different type of the methodologies and the ways in which these companies are operating but the most important thing is that there companies are not working without a sound management. The need of the strong management arises from the time of the making and researching on a bio technology product or conducting an advertising or corporative approach about your company.

These are the products that are come from the personalized products no one ready to buy the products by seeing the advertisement and by hearing about these things. People who are not operating in their fields are always not welcomed in biotechnology. So the handsome amount of the campaigns relating to their products is needed.  The bio technology related businesses and the firms whether they are of the great nature or however they are of the lower nature they are running and obeying the lectures of the  Lindsay Rosen Wald .

The multinational companies are running on the basis of their advertisement and the biotechnology products runs on the same nature of the business or the advertisement campaign like these multinational companies so the managers who came in these bio technology companies should adopt the potential ways and methods to operate these companies.  Lindsay Rosen Wald has providing the help about such type of business by practicing different type of promotional schemes in paramount bio technologies.

Rosenwald has moved to the Wall Street in the year 1986 by quitting his private medical practice. At the new place, Lindsay Rosenwald turn to be a special person by being in a most unique blend of two different kind of jobs  of Analyst as well as Physician. At that time, very few people were doing this blend of jobs and the number of people who were doing both these jobs at the same time was very much less. It is a common option that doctors cannot be good investors. But Rosenwald’s passion towards finance investments has made him to get success in both of his streams. He always wanted to explore the business world in finance investing and to implement it for the health care world. He tried a lot in this direction and there is good applause from the public. Now, he is respected all over for the service he has done to these field and also for his efforts that made advancements in those fields. For some period of time, Rosenwald has worked for a company called DH Blair and Company. He served at the position of managing director for corporate finance. In order to pay attention and to concentrate on his new firm and venture, he had to quit the job at DH Blair and Company. In the year 1991, Lindsay Rosenwald has established a company called Paramount Bio Tech. Then he started other companies which work under the same group. He has taken care that these companies emphasize equally on corporate or business aspects and bio technology aspects. This is the company which supports other new sprouting companies in the field of bio technology and in its way; this company has extended its support to more than twenty five companies in the past three years of time. There are many companies in the group of companies, together named as Paramount Group of Companies. Each of these companies in the group has their own identity and significance.

The company therefore assesses companies globally in the quest for the right candidate it could support. Once the right candidate that fits the company’s bill is identified, the executive Paramount Biosciences has become a global phenomenon. Paramount BioSciences has its foray into pharmaceutical progress; it also invests largely in the healthcare sector. The company’s vision is set at setting up newer companies; the activities of these new companies would chiefly be in concern with biotechnology and existence sciences. Paramount Biosciences would therefore assist these companies perfect from its inception to its being fully functional as a separate entity. The business has set its eye in developing newer therapeutic medications which the corporation believes has ample marketplace potential. The company therefore assesses companies globally in the quest for the right candidate it could support. Once the right candidate that fits the company’s bill is identified, the executive team of Paramount BioSciences takes over.

The expertise of Paramount’s Executive team is this kind of that the team thereon manages the entire advancement cycle of the medication including formulating the manufacturing process, transfer of technology, the pharmacology aspect, the toxicology aspect, clinical improvement aspect of the medication, the regulatory element of the drug, ensuring good quality, commercializing the drug, and hence the existence cycle management. The affiliate of Paramount BioSciences – Paramount BioCapital, Inc, which can be a FINRA registered broker-dealer is involved in the financial funding for this kind of ventures. The Paramount Biosciences is the brainchild of Dr. Lindsay Rosenwald, M.D. who is also the company’s current Chairman and Chief Executive Officer. Dr. Lindsay Rosenwald is a true visionary among his contemporaries. Many a pharmaceutical company nurtured through his Paramount BioSciences company has immensely contributed to humanity as a result of varied medication contributions. Drugs for cancer including leukemia, colon cancer and so on. has hit the marketplace in record time. The medicine Arsenic Trioxide holds a distinctive record for having received the approval of the FDA in the least feasible time. The pharmaceutical companies in the Parmount Biosciences portfolio included Indevus Pharmaceuticals, Keryx Biopharmaceuticals, Polarx, Cougar Biotechnology, Enzymed Corp, Javelin Pharmaceuticals etc. These pharmaceuticals have contributed several a living saving medication. Many among these portfolio companies have been acquired by major companies as a result of million and billion dollar deals depending on the drugs that had been under development in the respective companies.

In pursuit of his lifelong goal, Rosenwald joined Temple University’s University of Medicine. Following graduating from Temple University in 1983, he began an internship at Abington Hospital before beginning his own private practice. He worked as a doctor in his practice for two and a half years. Even though he cherished being a medical doctor, Rosenwald desired a profession where he could combine his two loves – medical science and business.

Rosenwald decide to depart private medical care in the mid eighties to take a job on Wall Street. The position he got was a Physician Analyst and amazingly fit exactly what he needed. Despite the misconception that doctors don’t make good investors, Dr Rosenwald excelled at this placement. He had a passion for growing investment finance open to the health care sector and that is primarily why he worked there. He received great admiration in his brand new placement, and though he missed his old private practice, he realized this is where he truly belonged. During this time, he also worked for DH Blair and Company, a private investment company, as the controlling director of corporate finance. Over time, he left D.H. Blair and Company to pay attention to a new venture and firm.

In 1991, Lindsay Rosenwald started Paramount Biotech. With time, he has expanded this company by establishing new companies and attaining control of other biotech companies. He has developed or financed over 40 companies – over 25 of that have been in the past 3 years. He can make these acquired businesses successful because he focuses on both improving the corporate structure of the organization, in addition to increasing the analysis portion. Now, Paramount Capital is comprised of a lot of companies. These companies include Paramount Biosciences, which produces and supports new biotechnology businesses, Paramount Corporate Improvement, which actively works to build the Paramount Corporation in addition to develop new medicines, and Paramount BioCapital, a broker-dealer that has raised over $950 billion in revenue since it started. The firms that Rosenwald controls have licensed or purchased over one hundred experimental stage medications.

One of the most notable achievements for Rosenwald is setting the record for the quickest approval of a new drug to market. In only thirty months, Arsenic Trioxide was created and authorized by the Food and drug administration for managing a deadly type of the leukemia disease. This medication has been in the marketplace globally for more than ten years and has saved and prolonged 1000s of lives.

Rosenwald has been groundbreaking with the businesses he has created. In one of the finest reverse mergers of all time, his company, Cougar Biotechnology, sold for over $1 billion to Johnson and Johnson, in spite of merely having a single medicine with phase two scientific data. He has also started the first publicly traded stem cell company, gene therapy company, and cancer vaccine company. As Rosenwald as the director, his businesses are creating probably the most valuable and groundbreaking drugs of the 21st century. He is also responsible for the very first successful anti-obesity drug created in the USA market in 30 years.

Many people credit the success of the biotech industry on a whole to Dr. Rosenwald. His visionary companies have altered many lives and made Dr. Rosenwald’s individual assets soar to the tune of $600 million.